Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation
Kazuaki Miyagawa, Hirofumi Tenshin, Patrick L. Mulcrone, Jesus Delgado-Calle, Mark A. Subler, Jolene J. Windle, John M. Chirgwin, G. David Roodman, Noriyoshi Kurihara
Kazuaki Miyagawa, Hirofumi Tenshin, Patrick L. Mulcrone, Jesus Delgado-Calle, Mark A. Subler, Jolene J. Windle, John M. Chirgwin, G. David Roodman, Noriyoshi Kurihara
View: Text | PDF
Research Article Bone biology Endocrinology

Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation

  • Text
  • PDF
Abstract

We previously reported that measles virus nucleocapsid protein (MVNP) expression in osteoclasts (OCLs) of patients with Paget disease (PD) or targeted to the OCL lineage in MVNP-transgenic mice (MVNP mice) increases IGF1 production in osteoclasts (OCL-IGF1) and leads to development of PD OCLs and pagetic bone lesions (PDLs). Conditional deletion of Igf1 in OCLs of MVNP mice fully blocked development of PDLs. In this study, we examined whether osteocytes (OCys), key regulators of normal bone remodeling, contribute to PD. OCys in PDLs of patients and of MVNP mice expressed less sclerostin, and had increased RANKL expression compared with OCys in bones from WT mice or normal patients. To test whether increased OCL-IGF1 is sufficient to induce PDLs and PD phenotypes, we generated TRAP-Igf1 (T-Igf1) transgenic mice to determine whether increased IGF1 expression in the absence of MVNP in OCLs is sufficient to induce PDLs and pagetic OCLs. We found that T-Igf1 mice at 16 months of age developed PD OCLs, PDLs, and OCys, with decreased sclerostin and increased RANKL, similar to MVNP mice. Thus, pagetic phenotypes could be induced by OCLs expressing increased IGF1. OCL-IGF1 in turn increased RANKL production in OCys to induce PD OCLs and PDLs.

Authors

Kazuaki Miyagawa, Hirofumi Tenshin, Patrick L. Mulcrone, Jesus Delgado-Calle, Mark A. Subler, Jolene J. Windle, John M. Chirgwin, G. David Roodman, Noriyoshi Kurihara

×

Figure 8

The detection of IGF1, bone structure, and histomorphometric analysis in WT and T-Igf1 mice.

Options: View larger image (or click on image) Download as PowerPoint
The detection of IGF1, bone structure, and histomorphometric analysis in...
(A) Detection of IGF1. Femur sections were stained with anti-IGF1. Arrows point to OCLs. Scale bars: 10 μm. Results are representative of 3 biological replicates. (B) Representative μCT images of fifth lumbar vertebrae. Scale bars: 1.0 mm. (C) Bone volume and structural parameters of trabecular bone in vertebrae. Results are mean ± SEM for WT, with blue indicating males and red females (5 males, 6 females, 16 ± 3 months), MVNP with PDL (3 females, 19 ± 1 months), and T-Igf1 with PDL (1 male, 5 females, 15 ± 1 months). The data were analyzed using 1-way ANOVA with Tukey’s test. (D) OCL morphology. OCLs in vertebral sections were stained for TRAP. Scale bars: 50 μm. Staining results are representative of 3 biological replicates. (E) Bone morphometric analysis. Results are expressed as the mean ± SEM for WT (3 males, 2 females, 16 ± 3 months), MVNP with PDL (1 male, 2 females, 21 ± 2 months), and T-Igf1 with PDL (1 male, 3 females, 15 ± 1 months). The data were analyzed using 1-way ANOVA with Tukey’s test. (F) Sclerostin in OCys. Femur sections from these mice were stained with anti-sclerostin antibody as described in Methods. Scale bars: 10 μm. Staining results are representative of 3 biological replicates. (G) Ratio of sclerostin-positive OCys/total OCys per area and canalicular length (0.25 mm square). Results are expressed as the mean ± SEM from WT (each 3 males and 4 females, 15 ± 1 months) and T-Igf1 with PDL (1 male, 4 females, 15 ± 1 months) from the same sections shown in F as described in Methods analyzed using 1-way ANOVA with Tukey’s test. BV/TV, trabecular bone volume fraction; Tb.Th, trabecular thickness; Tb.N, trabecular number; N.Oc/B.Pm, number of osteoclasts per bone perimeter.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts